These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32884102)

  • 1. SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers.
    Jang BG; Kim HS; Bae JM; Kim WH; Kim HU; Kang GH
    Sci Rep; 2020 Sep; 10(1):14591. PubMed ID: 32884102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer.
    Hyun CL; Park SJ; Kim HS; Song HJ; Kim HU; Lee C; Lee DH; Maeng YH; Kim YS; Jang B
    Anticancer Res; 2021 Jul; 41(7):3689-3698. PubMed ID: 34230168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression Profile and Prognostic Significance of EPHB3 in Colorectal Cancer.
    Jang BG; Kim HS; Bae JM; Kim WH; Hyun CL; Kang GH
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32294981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression Profile of LGR5 and Its Prognostic Significance in Colorectal Cancer Progression.
    Jang BG; Kim HS; Chang WY; Bae JM; Kim WH; Kang GH
    Am J Pathol; 2018 Oct; 188(10):2236-2250. PubMed ID: 30036518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of SMOC2 expression in papillary thyroid carcinoma and its prognostic significance.
    Kim HS; Choi JH; Lee JY; Kang J; Myung JK; Kim WH; Jang BG
    Sci Rep; 2020 Mar; 10(1):4853. PubMed ID: 32184420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of intestinal stem cell markers in colorectal precancerous lesions.
    Jang BG; Kim HS; Kim KJ; Rhee YY; Kim WH; Kang GH
    Histopathology; 2016 Mar; 68(4):567-77. PubMed ID: 26212207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer.
    Chang JY; Kim JH; Kang J; Park Y; Park SJ; Cheon JH; Kim WH; Kim H; Park JJ; Kim TI
    Yonsei Med J; 2020 Jul; 61(7):572-578. PubMed ID: 32608200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile of intestinal stem cell and cancer stem cell markers in gastric cancers with submucosal invasion.
    Kim HS; Song HJ; Kim HU; Jeong IH; Koh HM; Shin JH; Jang BG
    Pathol Res Pract; 2021 Feb; 218():153336. PubMed ID: 33450435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients.
    Chen X; Sun K; Jiao S; Cai N; Zhao X; Zou H; Xie Y; Wang Z; Zhong M; Wei L
    Sci Rep; 2014 Dec; 4():7481. PubMed ID: 25500546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LETM1 is a potential cancer stem-like cell marker and predicts poor prognosis in colorectal adenocarcinoma.
    Piao L; Feng Y; Yang Z; Qi W; Li H; Han H; Xuan Y
    Pathol Res Pract; 2019 Jul; 215(7):152437. PubMed ID: 31101574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
    Li Y; Liu YH; Hu YY; Chen L; Li JM
    World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of stromal GREM1 expression in colorectal cancer.
    Jang BG; Kim HS; Chang WY; Bae JM; Oh HJ; Wen X; Jeong S; Cho NY; Kim WH; Kang GH
    Hum Pathol; 2017 Apr; 62():56-65. PubMed ID: 28041973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
    Jang BG; Lee BL; Kim WH
    Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway.
    Bae JM; Kim JH; Rhee YY; Cho NY; Kim TY; Kang GH
    World J Gastroenterol; 2015 Sep; 21(33):9749-57. PubMed ID: 26361422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.